175 related articles for article (PubMed ID: 10228948)
1. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells.
Lu R; Serrero G
J Cell Physiol; 1999 Jun; 179(3):297-304. PubMed ID: 10228948
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
3. Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells.
Serrero G; Lu R
Antioxid Redox Signal; 2001 Dec; 3(6):969-79. PubMed ID: 11813992
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha.
Levenson AS; Gehm BD; Pearce ST; Horiguchi J; Simons LA; Ward JE; Jameson JL; Jordan VC
Int J Cancer; 2003 May; 104(5):587-96. PubMed ID: 12594813
[TBL] [Abstract][Full Text] [Related]
5. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
6. Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.
Kenney NJ; Saeki T; Gottardis M; Kim N; Garcia-Morales P; Martin MB; Normanno N; Ciardiello F; Day A; Cutler ML
J Cell Physiol; 1993 Sep; 156(3):497-514. PubMed ID: 8360257
[TBL] [Abstract][Full Text] [Related]
7. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
Jain PT; Pento JT; Magarian RA
Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
[TBL] [Abstract][Full Text] [Related]
8. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
9. Estradiol induction of retinoic acid receptors in human breast cancer cells.
Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL
Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407
[TBL] [Abstract][Full Text] [Related]
10. Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2.
Gehm BD; Levenson AS; Liu H; Lee EJ; Amundsen BM; Cushman M; Jordan VC; Jameson JL
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):223-34. PubMed ID: 15120416
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1.
Golkar L; Ding XZ; Ujiki MB; Salabat MR; Kelly DL; Scholtens D; Fought AJ; Bentrem DJ; Talamonti MS; Bell RH; Adrian TE
J Surg Res; 2007 Apr; 138(2):163-9. PubMed ID: 17257620
[TBL] [Abstract][Full Text] [Related]
12. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro.
Danforth DN; Sgagias MK
Cancer Res; 1991 Mar; 51(5):1488-93. PubMed ID: 1997187
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression.
Reddy KB; Yee D; Hilsenbeck SG; Coffey RJ; Osborne CK
Cell Growth Differ; 1994 Dec; 5(12):1275-82. PubMed ID: 7696176
[TBL] [Abstract][Full Text] [Related]
15. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
Cao Z; Fang J; Xia C; Shi X; Jiang BH
Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
17. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
Jeng MH; Parker CJ; Jordan VC
Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells.
Mgbonyebi OP; Russo J; Russo IH
Int J Oncol; 1998 Apr; 12(4):865-9. PubMed ID: 9499448
[TBL] [Abstract][Full Text] [Related]
19. Retinoid antagonism of estrogen-responsive transforming growth factor alpha and pS2 gene expression in breast carcinoma cells.
Fontana JA; Nervi C; Shao ZM; Jetten AM
Cancer Res; 1992 Jul; 52(14):3938-45. PubMed ID: 1319834
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.
Parisot JP; Hu XF; DeLuise M; Zalcberg JR
Br J Cancer; 1999 Feb; 79(5-6):693-700. PubMed ID: 10070856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
